BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16792508)

  • 1. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
    Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
    DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
    Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
    Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.
    Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikós T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P
    Nat Genet; 2002 Jul; 31(3):295-300. PubMed ID: 12089527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal location of murine protein tyrosine phosphatase (Ptprj and Ptpre) genes.
    Watanabe T; Mukouyama Y; Rhodes M; Thomas M; Kume T; Oishi M
    Genomics; 1995 Oct; 29(3):793-5. PubMed ID: 8575779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.
    Smart CE; Askarian Amiri ME; Wronski A; Dinger ME; Crawford J; Ovchinnikov DA; Vargas AC; Reid L; Simpson PT; Song S; Wiesner C; French JD; Dave RK; da Silva L; Purdon A; Andrew M; Mattick JS; Lakhani SR; Brown MA; Kellie S
    PLoS One; 2012; 7(7):e40742. PubMed ID: 22815804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites.
    Shintani T; Higashi S; Takeuchi Y; Gaudio E; Trapasso F; Fusco A; Noda M
    J Biochem; 2015 Sep; 158(3):235-43. PubMed ID: 26063811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.
    Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R
    FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
    Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
    Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation.
    Ortuso F; Paduano F; Carotenuto A; Gomez-Monterrey I; Bilotta A; Gaudio E; Sala M; Artese A; Vernieri E; Dattilo V; Iuliano R; Brancaccio D; Bertamino A; Musella S; Alcaro S; Grieco P; Perrotti N; Croce CM; Novellino E; Fusco A; Campiglia P; Trapasso F
    ACS Chem Biol; 2013 Jul; 8(7):1497-506. PubMed ID: 23627474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Structure, Function and Regulation of Protein Tyrosine Phosphatase Receptor Type J and Its Role in Diseases.
    Li H; Zhang P; Liu C; Wang Y; Deng Y; Dong W; Yu Y
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.
    Dubé N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML
    Cancer Res; 2005 Nov; 65(21):10088-95. PubMed ID: 16267035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A
    Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.
    Paduano F; Ortuso F; Campiglia P; Raso C; Iaccino E; Gaspari M; Gaudio E; Mangone G; Carotenuto A; Bilotta A; Narciso D; Palmieri C; Agosti V; Artese A; Gomez-Monterrey I; Sala M; Cuda G; Iuliano R; Perrotti N; Scala G; Viglietto G; Alcaro S; Croce CM; Novellino E; Fusco A; Trapasso F
    ACS Chem Biol; 2012 Oct; 7(10):1666-76. PubMed ID: 22759068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.
    Bilotta A; Dattilo V; D'Agostino S; Belviso S; Scalise S; Bilotta M; Gaudio E; Paduano F; Perrotti N; Florio T; Fusco A; Iuliano R; Trapasso F
    Oncotarget; 2017 Feb; 8(6):10091-10102. PubMed ID: 28052032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells.
    D'Agostino S; Lanzillotta D; Varano M; Botta C; Baldrini A; Bilotta A; Scalise S; Dattilo V; Amato R; Gaudio E; Paduano F; Palmieri C; Iuliano R; Perrotti N; Indiveri C; Fusco A; Gaspari M; Trapasso F
    Oncotarget; 2018 May; 9(34):23334-23348. PubMed ID: 29805737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.